In this issue of , Kwok and colleagues have provided a wealth of retrospective clinical data that greatly expands our appreciation for the prognostic importance of flow-cytometric residual disease measurement across a spectrum of clinical presentations in chronic lymphocytic leukemia (CLL).
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5159707 | PMC |
http://dx.doi.org/10.1182/blood-2016-11-745323 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!